News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Weissman has partnered in building 18 mRNA-capable Good Manufacturing Practice (GMP) sites to date across the world.
In 2024, Koo and Steager sat down with Penn Today to discuss this technology’s potential not only to brush teeth, but also to diagnose and treat infectious diseases–in teeth and beyond.
In this Penn Today article, Yang explains how her inventions begin with changes on a fundamental level that can then grow into scalable and impactful products.
The Philadelphia Business Journal recently released an article about robotics growth in Philadelphia.
Penn spinout EpiVario, a biotech company focusing on neuroepigenetics for addiction disorders, has acquired small molecule acetyl co-A synthetase-2 inhibitor (ACSS2i) portfolio.
Baleena, BlueWhale Bio, Treeswift and Verismo were all recognized.
Penn was highlighted in the Philadelphia Inquirer for investing $2 billion in profits from its health system into medical research and physician support over the past decade.
The program was well attended by professionals from across the globe in pharma, medtech and biotech industries and offered an incredible opportunity for networking and connection.
When the SMP is in a soft state, it allows the gripper to make good contact with the object and conform to objects with irregular shapes or surfaces.
In the article, Technical.ly highlights that Penn affiliated startups attracted over $1 billion in investment capital in 2023.